Cargando…
The clinical impact of COVID-19 epidemic in the hematologic setting
The rapid onset and worldwide spread of the COVID-19 epidemic (caused by SARS-CoV-2 coronavirus) has been associated with a profound impact in clinical practice also in the hematologic setting. First of all, given the immunosuppressive effect of many therapies that are normally administered to patie...
Autores principales: | Finelli, Carlo, Parisi, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364141/ https://www.ncbi.nlm.nih.gov/pubmed/32773103 http://dx.doi.org/10.1016/j.jbior.2020.100742 |
Ejemplares similares
-
Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients
por: Parisi, Sarah, et al.
Publicado: (2021) -
COVID-19: Review and hematologic impact
por: Letícia de Oliveira Toledo, Sílvia, et al.
Publicado: (2020) -
Impact of Covid-19 on Hematological Practice: Challenges and Opportunities
por: Kumar, Rajat
Publicado: (2020) -
THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
por: YILMAZ, Fatma, et al.
Publicado: (2021) -
COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting
por: Gadde, Saikrishna, et al.
Publicado: (2020)